Musunuri Balaji, Gopal Sandeep, Tantry Bailuru V, Shenoy Suresh, Shetty Anurag J
Department of Gastroenterology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Department of Gastroenterology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):989-996. doi: 10.1016/j.jceh.2023.05.017. Epub 2023 Jun 2.
Acute kidney injury (AKI) is known to be associated with increased short-term mortality among cirrhotic patients. On this background, we designed this study to evaluate various causes of AKI among admitted patients with cirrhosis of liver and predictors of 90-day mortality.
One hundred and two consecutive adult patients with cirrhosis of liver with AKI hospitalized between November 2016 and March 2018 were enrolled in this prospective study. Their detailed clinical profile, including biochemical parameters, the etiology of AKI, and their clinical outcome of survival or mortality at 90-days, were recorded.
The most common causes of AKI were infections, followed by hypovolemia, seen in 55.88% and 31.37% of the patients, respectively. Hepatorenal syndrome (HRS) was seen in 10.78%, while parenchymal renal disease was the least common (1.9%). The in-hospital mortality rate was 28.4%, while 90-day mortality was 39.21%. The HRS group had a high 90-day mortality rate of 54.54%. ROC analysis of various biochemical parameters revealed that serum creatinine (sCr), Model for End-Stage Liver Disease (MELD), International Normalized Ratio (INR), and Neutrophil-Lymphocyte ratio (NLR), followed by Child Turcotte Pugh (CTP), had high area under the curves of 0.785, 0.773, 0.747, 0.740, and 0.718, respectively, for the prediction of 90-day mortality.
Infection is the commonest cause of AKI in cirrhosis; however, mortality in patients with HRS-AKI is higher than that in those with infection-related AKI. Serum creatinine at admission, INR, NLR, and CTP scores predict short-term mortality among patients with AKI in cirrhosis. Further, large prospective studies are needed to confirm these findings.
已知急性肾损伤(AKI)与肝硬化患者短期死亡率增加有关。在此背景下,我们设计了本研究,以评估肝硬化住院患者中AKI的各种病因及90天死亡率的预测因素。
本前瞻性研究纳入了2016年11月至2018年3月期间连续住院的102例肝硬化合并AKI的成年患者。记录了他们详细的临床资料,包括生化参数、AKI的病因以及90天时的生存或死亡临床结局。
AKI最常见的病因是感染,其次是血容量不足,分别见于55.88%和31.37%的患者。肝肾综合征(HRS)见于10.78%的患者,而实质性肾病最不常见(1.9%)。住院死亡率为28.4%,90天死亡率为39.21%。HRS组90天死亡率高达54.54%。对各种生化参数进行ROC分析显示,血清肌酐(sCr)、终末期肝病模型(MELD)、国际标准化比值(INR)和中性粒细胞与淋巴细胞比值(NLR),其次是Child Turcotte Pugh(CTP)评分,预测90天死亡率的曲线下面积分别为0.785、0.773、0.747、0.740和0.718。
感染是肝硬化患者AKI最常见的病因;然而,HRS-AKI患者的死亡率高于感染相关性AKI患者。入院时的血清肌酐、INR、NLR和CTP评分可预测肝硬化合并AKI患者的短期死亡率。此外,需要进一步的大型前瞻性研究来证实这些发现。